Market Overview

PAREXEL Announces Appointment of Two Key Executives


PAREXEL International Corporation, the world's leading innovator of
biopharmaceutical services, today announced the appointment of Greg Rush
as Executive Vice President and Chief Financial Officer and Michele
Fournier as Senior Vice President and Chief Human Resources Officer.

This press release features multimedia. View the full release here:

Greg Rush, Executive Vice President and Chief Financial Officer (Photo: Business Wire)

Greg Rush, Executive Vice President and Chief Financial Officer (Photo: Business Wire)

Mr. Rush joins PAREXEL after serving as Executive Vice President and
Chief Financial Officer of Syneos Health, Inc. (formerly known as INC
Research Holdings, Inc.) from August 2013 to August 2017. Mr. Rush was
previously Senior Vice President and CFO of Tekelec, a leading high-tech
solutions and service provider that was acquired by Oracle. He also held
positions of increasing responsibility at Siebel Systems, Quintiles
Transnational Holdings, PricewaterhouseCoopers and Ernst & Young. He is
a Certified Public Accountant and has a Bachelor of Science in Business
and a Master of Accounting from the University of North Carolina at
Chapel Hill.

Ms. Fournier joined PAREXEL in 2014 and has served as the Company's
Corporate Vice President and Interim Chief Human Resources Officer since
January 2018. She will be responsible for working in partnership with
PAREXEL's executive leaders to drive high performance and develop the
Company's people and growth strategies. Prior to her current role, Ms.
Fournier served as Corporate Vice President for Compensation, Benefits
and HR M&A at PAREXEL. Previously, Ms. Fournier held a variety of senior
human resource leadership roles in the United States and abroad with
companies including PTC, Cambridge Technology Partners, William M.
Mercer and Medtronic. Ms. Fournier holds a Bachelor of Arts from the
University of Michigan and is a Certified Compensation Professional.

"We are pleased to welcome Greg and Michele to PAREXEL's leadership
team," said Jamie Macdonald, Chief Executive Officer of PAREXEL. "Greg's
extensive experience leading global financial operations within the CRO
and service industries will be incredibly beneficial to PAREXEL as we
look to drive successful growth, while Michele's deep human resources
expertise will drive the development and high performance of PAREXEL's
greatest asset – our people. These two leaders are a strong addition to
our organization as we work to deliver high quality service and
expertise to the industry."

Mr. Rush's appointment will be effective August 20, 2018 and Ms.
Fournier's was effective August 2, 2018. Both will be based at PAREXEL's
corporate headquarters in Waltham, Massachusetts.

About PAREXEL International
PAREXEL International
Corporation is the world's leading innovator of biopharmaceutical
services. We simplify our clients' journey of transforming scientific
discoveries into new medical treatments for patients with high-quality
Phase I-IV clinical research, regulatory, consulting and market access
services. PAREXEL develops breakthrough innovations and solutions by
leveraging its comprehensive therapeutic, technical and functional
expertise, in more than 100 countries around the world. For more
information visit

PAREXEL is a registered trademark of PAREXEL International Corporation.
All other trademarks are the property of their respective owners.

View Comments and Join the Discussion!